Uganda: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Uganda

The Ugandan market for other medicaments for therapeutic or prophylactic uses declined slightly to $X in 2022, remaining stable against the previous year. Overall, consumption, however, recorded a prominent expansion. Consumption of peaked at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Uganda

In value terms, production of other medicaments for therapeutic or prophylactic uses contracted to $X in 2022 estimated in export price. Over the period under review, production, however, recorded a resilient expansion. The pace of growth was the most pronounced in 2019 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2020 to 2022, production of growth remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Uganda

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons for the first time since 2019, thus ending a two-year rising trend. Over the period under review, exports continue to indicate a precipitous decrease. The growth pace was the most rapid in 2020 with an increase of X% against the previous year. The exports peaked at X tons in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses shrank significantly to $X in 2022. In general, exports recorded a dramatic downturn. The pace of growth appeared the most rapid in 2020 when exports increased by X%. Over the period under review, the exports of reached the peak figure at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Rwanda (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Uganda, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Rwanda exceeded the volume sent to the second major destination, Democratic Republic of the Congo (X kg), ninefold. Burundi (X kg) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual growth rate of volume to Rwanda stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Democratic Republic of the Congo (X% per year) and Burundi (X% per year).

In value terms, Rwanda ($X), Democratic Republic of the Congo ($X) and Tanzania ($X) were the largest markets for other medicaments for therapeutic or prophylactic uses exported from Uganda worldwide, together comprising X% of total exports.

Tanzania, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced a decline.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, surging by X% against the previous year. Over the period under review, the export price enjoyed temperate growth. The pace of growth was the most pronounced in 2020 an increase of X%. The export price peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Tanzania ($X per ton), while the average price for exports to Burundi ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Tanzania (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Uganda

In 2022, after two years of decline, there was significant growth in supplies from abroad of other medicaments for therapeutic or prophylactic uses, when their volume increased by X% to X tons. In general, imports, however, continue to indicate a slight shrinkage. The most prominent rate of growth was recorded in 2018 when imports increased by X% against the previous year. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses expanded modestly to $X in 2022. Over the period under review, imports recorded a modest increase. The most prominent rate of growth was recorded in 2019 when imports increased by X%. Imports peaked at $X in 2014; however, from 2015 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Jordan (X tons) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Uganda, accounting for a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Jordan exceeded the figures recorded by the second-largest supplier, India (X tons), fourfold. Iran (X kg) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Jordan stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Iran (X% per year).

In value terms, India ($X), Jordan ($X) and Iran ($X) constituted the largest other medicaments for therapeutic or prophylactic uses suppliers to Uganda, with a combined X% share of total imports.

In terms of the main suppliers, Iran, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, with a decrease of X% against the previous year. Overall, import price indicated a noticeable increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2018 indices. The pace of growth was the most pronounced in 2019 an increase of X% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2021, and then fell notably in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was South Africa ($X per ton), while the price for the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by New Zealand (X.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :